Fig. 3: The possible interactions between GAS6, AXL, GAS6-AS1, GAS6-DT, and other biomolecules that may be related to diabetes mellitus and diabetic nephropathy. | Nutrition & Diabetes

Fig. 3: The possible interactions between GAS6, AXL, GAS6-AS1, GAS6-DT, and other biomolecules that may be related to diabetes mellitus and diabetic nephropathy.

From: Association of GAS6, AXL, and GAS6-AS lncRNAs with nephropathy in Egyptian patients with type 2 diabetes mellitus: a case–control observational study

Fig. 3

This figure was drawn using PathVisio biological pathway editor, version 3.0.0+. Databases used for predictions were NPInter, miRTarBase, and TargetScan. Dashed lines represent predicted interactions. Solid lines represent verified interactions with references clarified as numbers (numbering 11 to 57 is the same as in the main manuscript). PubMed identifiers of references (PMID) (more details can be found under references): [11], 38390204; [31], 30515796; [32], 34649592; [33], 29572052; [34], 21576456; [35], 27613243; [36], 38935970; [37], 30584410; [38], 31570982; [39], 37113991; [40], 38270305; [41], 32959695; [42], 32215042; [43], 28923913; [44], 37251672; [45], 34934434; [46], 36765416; [47], 32104036; [48], 31485601; [49], 35121168; [50], 29321583; [51], 34238205; [52], 30394665; [53], 32664305; [54], 31933797; [55], 36722214; [56], 35793478; [57], https://doi.org/10.1166/mex.2023.2424. DM diabetes mellitus, DN diabetic nephropathy, EMT epithelial–mesenchymal transition.

Back to article page